Are you Dr. Zaragoza?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Uci Medical Center
101 The City Drive South
Orange, CA 92868Phone+1 714-456-8978
Summary
- Dr. Michael V Zaragoza, MD is a board certified medical geneticist in Orange, California. He is currently licensed to practice medicine in California. He is affiliated with UCI Health and is an Assistant Professor at University of California.
Education & Training
- University of California (Irvine)Residency, Pediatrics/Medical Genetics and Genomics, 2000 - 2005
- Case Western Reserve University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2001 - 2025
- American Board of Medical Genetics and Genomics Clinical Genetics
Clinical Trials
- The Genetics of Cardiomyopathy and Heart Failure Start of enrollment: 2007 Apr 01
Publications & Presentations
PubMed
- 5 citationsA Study of Gene Expression, Structure, and Contractility of iPSC-Derived Cardiac Myocytes from a Family with Heart Disease due to LMNA MutationMehrsa Mehrabi, Tessa Altair Morris, Zixuan Cang, Cecilia H. H. Nguyen, Yutong Sha
Annals of Biomedical Engineering. 2021-09-28 - 5 citationsDNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.Julien L. P. Morival, Halida P. Widyastuti, Cecilia H. H. Nguyen, Michael V. Zaragoza, Timothy L. Downing
Clinical Epigenetics. 2021-07-10 - 6 citationsGene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesisHalida P. Widyastuti, Trina M. Norden-Krichmar, Anna Grosberg, Michael V. Zaragoza
BMC Medical Genetics. 2020-07-22
Grant Support
- Mitochondrial Dysfunction &Noncompaction CardiomyopathyNational Heart, Lung, And Blood Institute2006–2010